Michael W. Dunne Insider Trading $VXRT Vaxart, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Michael W. Dunne.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Michael W. Dunne. Michael W. Dunne is Director in Aviragen Therapeutics, Inc. ($NABI) and Chief Medical Officer in Durata Therapeutics, Inc. ($DRTX) and Chief Scientific Officer in Iterum Therapeutics plc ($ITRM) and Director in Iterum Therapeutics plc ($ITRM).

Michael W. Dunne in Vaxart, Inc.

Trading Symbol: VXRT
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Michael W. Dunne: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 22 2017
$VXRT Market Capitalization: $43.28M
$VXRT Previous Close: $1.14

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Michael W. Dunne in Vaxart, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, DRTX, ITRM, VXRT

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 22 2017AVIRAviragen Therapeut ...Dunne Michael W.DirectorOption ExerciseA0.4920,0009,80075,000
May 13 2016NABIAviragen Therapeut ...Dunne Michael W.DirectorOption ExerciseA1.5020,00030,00020,000
Oct 21 2015NABIAviragen Therapeut ...Dunne Michael W.DirectorOption ExerciseA1.9535,00068,25035,000

Page:   1